Genethera Overview

  • Status
  • Public
  • Employees
  • 2
Employees
  • Stock Symbol
  • GTHR
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.01
  • (As of Wednesday Closing)

Genethera General Information

Description

GeneThera Inc is a biotechnology company. The company using its proprietary molecular sciences and technologies dedicated to eradicating diseases such as COVID-19, Paratuberculosis, Mad Cow Disease, Chronic Wasting Disease, and E.coli and Salmonella infections. It focuses on developing novel molecular diagnostic tests, therapeutics, and vaccines through their proprietary robotic technologies. It's Molecular Robotic/AI Platform and Therapeutic strategy (MORAPAT) is designed to prevent the spread of disease from animals and at the same time, allow better control of zoonotic infectious agents. The company has also developed a molecular system for the detection of Mycobacterium Avian Paratuberculosis in the milk of infected dairy cows.

Contact Information

Formerly Known As
Hand Brand Distribution
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Medical Supplies
Stock Exchange
PINX
Primary Office
  • 7577 West 103rd Avenue
  • Suite 212
  • Westminster, CO 80021
  • United States
+1 (303) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genethera Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.01 $356K 24.1M 36.5K -$0.02

Genethera Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 1,264 280 1,605 401
Revenue 0 0 0 0
EBITDA (842) (484) (3,273) (611)
Net Income (853) (518) (3,396) (758)
Total Assets 24 21 38 206
Total Debt 791 822 1,217 1,309
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genethera Executive Team (2)

Name Title Board Seat Contact Info
Tannya Irizarry Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
To view Genethera’s complete executive team members history, request access »

Genethera Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genethera Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000000 25-Jan-2012 000000000000000000 Other Healthcare Services 0000000 000000
Applied Genetics 13-Dec-2006 Joint Venture Other Healthcare Services 0000000 000000
To view Genethera’s complete investments and acquisitions history, request access »